Ernexa Therapeutics Inc. (ERNAW) Revenue 2015–2025
Ernexa Therapeutics Inc. (ERNAW) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$582,000FY2025 · since FY2015: $26.0M → $582,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $582,000 | +755.9% |
| FY2024 | $68,000 | — |
| FY2023 | $0 | — |
| FY2021 | $5.8M | -70.7% |
| FY2020 | $19.8M | -15.1% |
| FY2019 | $23.3M | +9.7% |
| FY2018 | $21.3M | -4.7% |
| FY2017 | $22.3M | -9.0% |
| FY2016 | $24.5M | -5.9% |
| FY2015 | $26.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice